Quantcast

Latest Prostate cancer Stories

2014-05-06 16:29:13

LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapieshttp://www.reportbuyer.com/pharma_healthcare/diseases/solid_tumors_market_asia_pacific_2019_new_drug_approvals_anticipated_product_launches_trigger_shift_treatment_paradigm_targeted_therapies.htmlSolid Tumors Market in Asia Pacific to...

2014-05-06 08:35:05

New Prognostic Biopsy Test Is Designed To Guide Individual Treatment Decisions About Prostate Cancer CAMBRIDGE, Mass., May 6, 2014 /PRNewswire/ -- Metamark Genetics, Inc. today announced that it has initiated clinical use of the company's ProMark(TM) prognostic test to help guide the medical management of patients with early-stage prostate cancer. ProMark(TM) is the first and only proteomic multiplex assay for intact biopsy tissue to assess the potential aggressiveness of...

2014-05-06 08:33:30

TOKYO and SAN FRANCISCO, May 6, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) to extend the indication for XTANDI® (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy. This sNDA application was granted Priority Review...

2014-05-05 23:01:21

Award Encourages Young Investigators to Take Risks in Search of a Cure Cold Spring Harbor, NY (PRWEB) May 05, 2014 The Pershing Square Sohn Cancer Research Alliance is honoring Lloyd Trotman, Associate Professor at Cold Spring Harbor Laboratory (CSHL). Trotman will receive one of six prizes for Young Investigators in Cancer Research, which seeks to fuel innovative scientific discoveries in the search for a cure for cancer. A member of the CSHL faculty since 2007, Trotman has focused on...

2014-05-05 08:28:31

New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in breast, colon, prostate and renal cancer will be presented at the American Society of Clinical Oncology(®) (ASCO(®)) Annual Meeting, taking place May 30 - June 3, 2014 at McCormick Place...

2014-05-04 20:21:32

Alliance of Australian and U.S. researchers and children's cancer advocates focused on developing drugs as potential treatments for neuroblastoma, the most common solid form of childhood cancer SYDNEY and COLUMBUS, Ohio, May 4, 2014 /PRNewswire/ -- Researchers and children's cancer advocates in Australia and the U.S. have formed a unique research and development alliance to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of...

2014-05-02 08:25:16

Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Oncologist published positive results from an Oncotype DX(®) colon cancer decision impact study, demonstrating that Recurrence Score(®) results changed treatment recommendations in 45 percent of stage II colon cancer patients. The study was conducted in collaboration with the...

Vitamin D Deficiency And Prostate Cancer
2014-05-02 05:33:40

Brett Smith for redOrbit.com - Your Universe Online In the past, vitamin D deficiency has been linked to conditions such as bone pain and muscle weakness – but a new report has found that a lack of the “sunshine vitamin” is related to a higher risk for aggressive prostate cancer. Published in the journal Clinical Cancer Research, the new report included European-American and African-American men who experienced their first prostate biopsy due to unusual prostate-specific antigen...

2014-05-01 16:30:43

Lemonade Stand Funds Fight against Lung Cancer WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation announces the Bauer family of Shaker Heights, Ohio - Harriet and her children, seventh grader Greta and fourth grader Owen - as the May LUNGevity Hero for their contributions to the fight against lung cancer. Since 2009, the family has run an after-school lemonade stand every Friday, providing tasty treats to the local community while raising funds for lung cancer research....

2014-04-30 16:30:20

Conference call to be held on Wednesday, April 30, 2014 at 4:30 p.m. Eastern Time BOTHELL, Wash. and VANCOUVER, British Columbia, April 30, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and anticipated near-term milestones and announced first quarter 2014 financial results. Clinical Developments and Anticipated Near-term Milestones -- Custirsen -- Top-line survival results announced on April 28, 2014...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.